Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets-Reference-Cited by-同舟云学术

Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets

Published:2016-12 Issue:12 Volume:23 Page:1490-1503
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Knezevic Claire E.,Wright Gabriela,Remsing Rix Lily L.,Kim Woosuk,Kuenzi Brent M.,Luo Yunting,Watters January M.,Koomen John M.,Haura Eric B.,Monteiro Alvaro N.,Radu Caius,Lawrence Harshani R.,Rix Uwe

Funder

H. Lee Moffitt Cancer Center and Research Institute

Miles for Moffitt

V Foundation

National Cancer Institute

Florida Department of Health

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference55 articles.

1. Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis;Andrabi;Proc. Natl. Acad. Sci. USA,2014

2. Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors;Antolin;Oncotarget,2014

3. Quantitative chemical proteomics profiling differentiates erlotinib from gefitinib in EGFR wild-type non-small cell lung carcinoma cell lines;Augustin;Mol. Cancer Ther.,2013

4. Hexose-6-phosphate dehydrogenase: linking endocrinology and metabolism in the endoplasmic reticulum;Banhegyi;J. Mol. Endocrinol.,2009

5. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors;Bantscheff;Nat. Biotechnol.,2007

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The PARP inhibitor rucaparib blocks SARS‐CoV‐2 virus binding to cells and the immune reaction in models of COVID‐19;British Journal of Pharmacology;2024-08-27

2. Probing intracellular determinants of PARP inhibitor selectivity and pharmacology with CeTEAM;2024-08-10

3. BRCAness, DNA gaps, and gain and loss of PARP inhibitor–induced synthetic lethality;Journal of Clinical Investigation;2024-07-15

4. Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery;Expert Opinion on Drug Discovery;2024-07-14

5. Senataxin deficiency disrupts proteostasis through nucleolar ncRNA-driven protein aggregation;Journal of Cell Biology;2024-05-08